» Articles » PMID: 11570977

Electrolytic Ablation of the Rat Pancreas: a Feasibility Trial

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2001 Sep 26
PMID 11570977
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatic cancer is a biologically aggressive disease with less than 20% of patients suitable for a "curative" surgical resection. This, combined with the poor 5-year survival indicates that effective palliative methods for symptom relief are required. Currently there are no ablative techniques to treat pancreatic cancer in clinical use. Tissue electrolysis is the delivery of a direct current between an anode and cathode to induce localised necrosis. Electrolysis has been shown to be safe and reliable in producing hepatic tissue and tumour ablation in animal models and in a limited number of patients. This study investigates the feasibility of using electrolysis to produce localised pancreatic necrosis in a healthy rat model.

Method: Ten rats were studied in total. Eight rats were treated with variable "doses" of coulombs, and the systemic and local effects were assessed; 2 rats were used as controls.

Results: Seven rats tolerated the procedure well without morbidity or mortality, and one died immediately post procedure. One control rat died on induction of anaesthesia. Serum amylase and glucose were not significantly affected.

Conclusion: Electrolysis in the rat pancreas produced localised necrosis and appears both safe, and reproducible. This novel technique could offer significant advantages for patients with unresectable pancreatic tumours. The next stage of the study is to assess pancreatic electrolysis in a pig model, prior to human pilot studies.

Citing Articles

The combination of electroporation and electrolysis (E2) employing different electrode arrays for ablation of large tissue volumes.

Klein N, Guenther E, Botea F, Pautov M, Dima S, Tomescu D PLoS One. 2019; 14(8):e0221393.

PMID: 31437212 PMC: 6705851. DOI: 10.1371/journal.pone.0221393.


The problems of radiofrequency ablation as an approach for advanced unresectable ductal pancreatic carcinoma.

Pezzilli R, Ricci C, Serra C, Casadei R, Monari F, DAmbra M Cancers (Basel). 2013; 2(3):1419-31.

PMID: 24281165 PMC: 3837314. DOI: 10.3390/cancers2031419.


Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer.

Ota S, Geschwind J, Buijs M, Wijlemans J, Kwak B, Ganapathy-Kanniappan S Target Oncol. 2013; 8(2):145-51.

PMID: 23529644 DOI: 10.1007/s11523-013-0273-x.


Perductal electrolytic ablation of the porcine pancreas: a minimally invasive option-studies of morbidity and mortality.

Morrison C, Court F, Wemyss-Holden S, Teague B, Burrell A, Texler M Surg Endosc. 2005; 18(10):1435-41.

PMID: 15791365 DOI: 10.1007/s00464-003-9270-y.

References
1.
Schwarz R, McCarty T, Peralta E, Diamond D, Ellenhorn J . An orthotopic in vivo model of human pancreatic cancer. Surgery. 1999; 126(3):562-7. View

2.
Blackwell T, Debelak J, Venkatakrishnan A, Schot D, Harley D, Pinson C . Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery. 1999; 126(3):518-26. View

3.
Merkle E, Haaga J, Duerk J, Jacobs G, Brambs H, Lewin J . MR imaging-guided radio-frequency thermal ablation in the pancreas in a porcine model with a modified clinical C-arm system. Radiology. 1999; 213(2):461-7. DOI: 10.1148/radiology.213.2.r99nv21461. View

4.
Rosenberg B, VANCAMP L, KRIGAS T . INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE. Nature. 1965; 205:698-9. DOI: 10.1038/205698a0. View

5.
Wemyss-Holden S, Hall P, Robertson G, Dennison A, Vanderzon P, Maddern G . The safety of electrolytically induced hepatic necrosis in a pig model. Aust N Z J Surg. 2000; 70(8):607-12. DOI: 10.1046/j.1440-1622.2000.01907.x. View